Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
Abstract
The benefits of triple therapy for chronic obstructive pulmonary disease (COPD) with an inhaled glucocorticoid, a long-acting muscarinic antagonist (LAMA), and a long-acting β2-agonist (LABA), as compared with dual therapy (either inhaled glucocorticoid–LABA or LAMA–LABA), are...
Paper Details
Title
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
Published Date
May 3, 2018
Volume
378
Issue
18
Pages
1671 - 1680
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History